CTT Pharmaceutical (CTTH) CEO Buys 2,100 Shares

What Happened The company's CEO reported a purchase of 2,100 shares of CTT Pharmaceutical Holdings, Inc. (CTTH). The transaction is coded as a purchase (P) and is described as an "Open market or private purchase" at $0.06 per share, for a total reported value of about $116. This was a buy (a purchase), which is generally a more informative signal than routine selling, though the dollar amount is very small.

Key Details

• Transaction date and filing date: Aug 24, 2026 (transaction and Form 4 filed the same day).
• Price and quantity: 2,100 shares at $0.06 per share; total ≈ $116.
• Transaction code: P (purchase) — described as "Open market or private purchase" on the Form 4.
• Shares owned after the transaction: Not disclosed in the provided filing.
• Footnotes/notable items: No 10b5-1 plan, tax withholding, or other footnotes were reported in the summary provided.
• Timeliness: Filing appears timely (no late filing flag).

Context Insider purchases can suggest confidence in the company, but this purchase is very small in dollar terms (~$116) and therefore represents a minimal added economic stake. For retail investors, larger and repeated insider purchases typically carry more weight than a single, low-value buy.